The U.S. Food and Drug Administration issued a draft guidance Thursday on its enforcement policy for tobacco products, saying retailers have 30 days to sell off products that are not similar to FDA-approved products.

Retailers may receive a letter to stop selling not substantially equivalent, or NSE, products, meaning the products are not similar to already legally marketed products, therefore retailers can’t sell those products until they are cleared by the FDA.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]